- Senior Investigator, Laboratory of Molecular Biology and Immunology
Dr. Arya Biragyn received his Ph.D. from the Institute of Molecular Biology at Engelgardt, Academy of Sciences of Russia, Moscow, in 1991. He obtained postdoctoral training from the University of Illinois at Urbana from 1991-1992 and the National Cancer Institute from 1992-1996. From 1996-2000 he was a scientist at the Science International Applications Corp. in Frederick, MD, where he worked on the development of new generation therapeutic vaccines for B cell lymphomas. In 2000 he moved to the Vaccine Biology Section, National Cancer Institute as a Staff Scientist, where he continued his cancer vaccine studies. From 2003 to 2011, he was a tenure-track investigator at the Laboratory of Immunology and, since 2011, he is a tenured senior investigator at the Laboratory of Molecular Biology and Immunology, National Institute on Aging.
- (2019). Potential importance of B cells in aging and aging-associated neurodegenerative diseases (vol 39, pg 283, 2017). Seminars in Immunopathology. 41(2), 277-277.
- (2019). Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model. BRAIN BEHAVIOR AND IMMUNITY. 75, 163-180.
- (2019). Tumor-Derived Thymic Stromal Lymphopoietin Expands Bone Marrow B-cell Precursors in Circulation to Support Metastasis. CANCER RESEARCH. 79(22), 5826-5838.
- (2018). Altered Extracellular Vesicle Concentration, Cargo, and Function in Diabetes. DIABETES. 67(11), 2377-2388.